WO2026099768 - METHODS OF MAKING CARDIOMYOCYTES
National phase entry is expected:
Publication Number
WO/2026/099768
Publication Date
15.05.2026
International Application No.
PCT/IB2025/061322
International Filing Date
05.11.2025
Title **
[English]
METHODS OF MAKING CARDIOMYOCYTES
[French]
MÉTHODES DE PRODUCTION DE CARDIOMYOCYTES
Applicants **
UNIVERSITY HEALTH NETWORK
Inventors
LAFLAMME, Michael
ALIBHAI, Faisal
Priority Data
63/716,480
05.11.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2266 | |
| EPO | Filing, Examination, Granting | 14311 | |
| Japan | Filing, Examination, Granting | 2337 | |
| South Korea | Filing, Examination, Granting | 2432 | |
| USA | Filing, Examination, Granting | 5340 |

Total:
26,686
Contact Us
Abstract[English]
This disclosure describes methods and materials for producing cardiomyocytes from pluripotent stem cells.[French]
La présente divulgation concerne des procédés et des matières pour la production de cardiomyocytes à partir de cellules souches pluripotentes.